Home / Adalimumab / Sweden
SE ATC L04AB04 · updated 2 Nov 2026
Adalimumab shortage in Sweden
Is there an Adalimumab shortage in Sweden?
Yes. As of 2 Nov 2026, 2 Adalimumab products are reported short in Sweden, the first since 21 Jul 2026. The company estimate for the return is 1 Feb 2027. Main reason: not stated.
Also short in United States, Germany, Italy, Spain, Austria, Belgium, Czechia. All countries.
Affected products in Sweden
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| SE | Hukyndra 40 mg Förfylld injektionspenna, 6 st | STADA Arzneimittel AG | 21 Jul 2026 | 1 Feb 2027 | Not stated |
| SE | Hukyndra 40 mg Förfylld injektionspenna, 2 st | STADA Arzneimittel AG | 29 Jul 2026 | 1 Feb 2027 | Not stated |
Source
Läkemedelsverket (Swedish Medical Products Agency). Official list. Ongoing and announced shortages (restanmälningar) reported by companies; one row per pack.